Go Pro

Modular Medical (MODD) Competitors

Modular Medical logo
$2.64 -0.34 (-11.41%)
Closing price 04:00 PM Eastern
Extended Trading
$2.58 -0.06 (-2.46%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MODD vs. NRXS, OM, SPAI, NNOX, and LNSR

Should you buy Modular Medical stock or one of its competitors? MarketBeat compares Modular Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Modular Medical include NeurAxis (NRXS), Outset Medical (OM), Safe Pro Group (SPAI), Nano-X Imaging (NNOX), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.

How does Modular Medical compare to NeurAxis?

Modular Medical (NASDAQ:MODD) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

In the previous week, Modular Medical had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Modular Medical and 0 mentions for NeurAxis. Modular Medical's average media sentiment score of 0.20 beat NeurAxis' score of 0.00 indicating that Modular Medical is being referred to more favorably in the media.

Company Overall Sentiment
Modular Medical Neutral
NeurAxis Neutral

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 21.1% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Modular Medical has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

NeurAxis has a consensus price target of $13.00, suggesting a potential upside of 89.50%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts plainly believe NeurAxis is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NeurAxis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Modular Medical has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -286.34% -216.26%
NeurAxis -492.76%N/A -641.25%

NeurAxis has higher revenue and earnings than Modular Medical. NeurAxis is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$28.24M-$14.71N/A
NeurAxis$4.28M19.84-$14.63M-$0.81N/A

Summary

NeurAxis beats Modular Medical on 9 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Modular Medical has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-63.65% -56.13% -27.45%
Modular Medical N/A -286.34%-216.26%

27.5% of Modular Medical shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by insiders. Comparatively, 7.1% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Outset Medical presently has a consensus target price of $10.00, suggesting a potential upside of 146.31%. Given Outset Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Outset Medical is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Outset Medical has a beta of 1.95, indicating that its share price is 95% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.48M0.63-$81.65M-$4.16N/A
Modular MedicalN/AN/A-$28.24M-$14.71N/A

In the previous week, Outset Medical had 2 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Outset Medical and 1 mentions for Modular Medical. Outset Medical's average media sentiment score of 0.93 beat Modular Medical's score of 0.20 indicating that Outset Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Modular Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Outset Medical beats Modular Medical on 10 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Safe Pro Group?

Safe Pro Group (NASDAQ:SPAI) and Modular Medical (NASDAQ:MODD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Safe Pro Group had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Safe Pro Group and 1 mentions for Modular Medical. Safe Pro Group's average media sentiment score of 0.65 beat Modular Medical's score of 0.20 indicating that Safe Pro Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Safe Pro Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Modular Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Safe Pro Group currently has a consensus price target of $11.00, suggesting a potential upside of 194.12%. Given Safe Pro Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Safe Pro Group is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Safe Pro Group has a beta of 3.52, indicating that its stock price is 252% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

Safe Pro Group has higher revenue and earnings than Modular Medical. Safe Pro Group is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K128.08-$14.32M-$0.71N/A
Modular MedicalN/AN/A-$28.24M-$14.71N/A

27.5% of Modular Medical shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Modular Medical has a net margin of 0.00% compared to Safe Pro Group's net margin of -800.91%. Safe Pro Group's return on equity of -119.17% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
Modular Medical N/A -286.34%-216.26%

Summary

Safe Pro Group beats Modular Medical on 13 of the 16 factors compared between the two stocks.

How does Modular Medical compare to Nano-X Imaging?

Modular Medical (NASDAQ:MODD) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Modular Medical has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -286.34% -216.26%
Nano-X Imaging -716.44%-70.96%-62.26%

Modular Medical has higher earnings, but lower revenue than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$28.24M-$14.71N/A
Nano-X Imaging$13.02M5.93-$75.02M-$1.58N/A

Nano-X Imaging has a consensus price target of $4.00, suggesting a potential upside of 260.36%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Nano-X Imaging had 17 more articles in the media than Modular Medical. MarketBeat recorded 18 mentions for Nano-X Imaging and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.20 beat Nano-X Imaging's score of 0.00 indicating that Modular Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Modular Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
0 Very Positive mention(s)
0 Positive mention(s)
18 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Nano-X Imaging beats Modular Medical on 10 of the 16 factors compared between the two stocks.

How does Modular Medical compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

LENSAR has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

LENSAR presently has a consensus target price of $10.00, indicating a potential upside of 73.91%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts clearly believe LENSAR is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

LENSAR has a net margin of 50.94% compared to Modular Medical's net margin of 0.00%. LENSAR's return on equity of -183.19% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR50.94% -183.19% 42.26%
Modular Medical N/A -286.34%-216.26%

40.2% of LENSAR shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 65.8% of LENSAR shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, LENSAR and LENSAR both had 1 articles in the media. LENSAR's average media sentiment score of 1.90 beat Modular Medical's score of 0.20 indicating that LENSAR is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LENSAR
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Modular Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Modular Medical has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$58.44M1.21-$34.28M-$0.58N/A
Modular MedicalN/AN/A-$28.24M-$14.71N/A

Summary

LENSAR beats Modular Medical on 12 of the 14 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MODD vs. The Competition

MetricModular MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$16.13M$8.90B$6.90B$12.28B
Dividend YieldN/A2.49%2.67%9.39%
P/E Ratio-0.1816.0427.1023.94
Price / SalesN/A7.21517.5191.92
Price / CashN/A18.5526.6847.25
Price / Book0.953.2610.666.14
Net Income-$28.24M$230.22M$3.60B$331.74M
7 Day Performance-33.83%-2.87%-1.51%-1.72%
1 Month Performance-48.74%-1.97%1.11%-1.44%
1 Year Performance-87.25%0.36%23.77%16.97%

Modular Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MODD
Modular Medical
0.7146 of 5 stars
$2.64
-11.4%
N/A-85.6%$16.13MN/AN/A20
NRXS
NeurAxis
1.3958 of 5 stars
$6.98
-2.4%
$13.00
+86.2%
+157.6%$86.44M$4.28MN/A19
OM
Outset Medical
3.74 of 5 stars
$4.53
-0.2%
$10.00
+120.8%
-75.9%$83.99M$119.48MN/A520
SPAI
Safe Pro Group
2.4269 of 5 stars
$3.87
+0.8%
$10.00
+158.4%
-2.8%$80.84M$610KN/A11
NNOX
Nano-X Imaging
3.0618 of 5 stars
$1.08
+1.9%
$4.00
+270.4%
-78.2%$75.16M$13.02MN/A190

Related Companies and Tools


This page (NASDAQ:MODD) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners